Cleared Traditional

ENDOSCOPICALLY DELIVERALBE ULTRASOUND POINT PORBE SYSTEM (ENDOSCOPY) (K971528) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1997
Decision
228d
Days
Class 2
Risk

K971528 is an FDA 510(k) clearance for the ENDOSCOPICALLY DELIVERALBE ULTRASOUND POINT PORBE SYSTEM (ENDOSCOPY). Classified as System, Imaging, Pulsed Echo, Ultrasonic (product code IYO), Class II - Special Controls.

Submitted by Fujinon, Inc. (New York, US). The FDA issued a Cleared decision on December 12, 1997 after a review of 228 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1560 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Fujinon, Inc. devices

Submission Details

510(k) Number K971528 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 28, 1997
Decision Date December 12, 1997
Days to Decision 228 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
121d slower than avg
Panel avg: 107d · This submission: 228d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IYO System, Imaging, Pulsed Echo, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYO System, Imaging, Pulsed Echo, Ultrasonic

All 176
Devices cleared under the same product code (IYO) and FDA review panel - the closest regulatory comparables to K971528.
SONOLINE ELEGRA DIAGNOSTIC ULTRASOUND SYSTEM
K981626 · Siemens Medical Solutions USA, Inc. · May 1998
SONOS 5500 ULTRASOUND IMAGING SYSTEM
K980687 · Hewlett-Packard Co. · May 1998
GALAXY INTRAVASCULAR ULTRASOUND SYSTEM, MODEL I5028
K980851 · Boston Scientific Corp · Apr 1998
SONOLINE VERSA 555 DIAGNOSTIC ULTRASOUND SYSTEM
K962142 · Siemens Medical Solutions USA, Inc. · May 1997
SONOLINE VERSA PRO DIAGNOSTIC ULTRASOUND SYSTEM
K962882 · Siemens Medical Solutions USA, Inc. · Apr 1997
PHILIPS SONO DIAGNOST 800
K963706 · Hewlett-Packard Co. · Mar 1997